Company Analysis

TherapeuticsMD, Inc. (TXMD)

Nasdaq: TXMD · Pharmaceutical Preparations · Boca Raton, FL · filing with the SEC since 1995
Grade5.5
◀ Past 4.3● Present 6.7▶ Future 5.2
1 est.

Income statement, as filed

In US dollars (USD), as filed; per-share figures in US dollars; share counts. The fiscal year ends in December.
Income statement, by fiscal year, newest first
Fiscal yearFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
Period endingDec 31, 2025Dec 31, 2024Dec 31, 2023Dec 31, 2022Dec 31, 2021Dec 31, 2020Dec 31, 2019Dec 31, 2018Dec 31, 2017Dec 31, 2016
Report filedMar 30, 2026Mar 27, 2025Mar 29, 2024Apr 7, 2023Mar 23, 2022Mar 4, 2021Feb 24, 2020Feb 27, 2019Feb 23, 2018Feb 28, 2017
Revenue3,022,0001,761,0001,302,00069,963,0002,573,000r64,872,00049,647,00016,099,46016,777,71319,356,450
Cost of revenue···1,397,0001,402,000r15,975,000r6,335,000r2,737,6522,636,9434,185,708
Gross profit··1,302,00068,566,0001,171,000r48,897,000r43,312,000r13,361,80814,140,77015,170,742
Research and development····7,086,00010,432,000r19,792,000r27,299,13833,852,99353,943,477
Selling, general and administrative·4,744,0008,903,000··192,963,967174,112,612115,988,95457,703,37051,348,414
Sales and marketing····108,195,000117,052,000114,231,000···
General and administrative6,852,0006,096,0008,903,00056,710,000r80,748,000r76,954,00060,494,000···
Total operating expenses7,412,0007,873,000r9,825,00067,375,00080,748,000r204,438,000r194,517,000r143,581,97891,769,480105,424,342
Operating income-4,390,000-6,112,000r-8,523,0001,191,000-79,577,000r-155,541,000r-151,205,000r-130,220,170-77,628,710-90,253,600
Interest expense8,00010,000r166,60013,500,000r22,568,00026,049,00016,526,0004,677,834··
Interest and investment income142,000135,000297,900······10,824
Other income (expense), net···-117,000272,000·····
Total non-operating income (expense)3,737,0003,769,000r781,000-117,000272,000r-27,983,000r-24,940,000r-2,396,990703,330378,141
Income before income taxes-653,000-2,343,000-7,742,0001,074,000-79,305,000r-183,524,000r-176,145,000r-132,617,160-76,925,380-89,875,459
Income tax expense·-31,000-43,000·······
Income from continuing operations-653,000-2,312,000-7,699,0001,074,000-79,305,000·····
Income from discontinued operations84,000131,000-2,579,000110,923,000-93,110,000·····
Net income-569,000-2,181,000-10,278,000111,997,000-172,415,000-183,524,000r-176,145,000r-132,617,160-76,925,380-89,875,459
Earnings per share, basic-0.05-0.19-0.99r12.41-21.66·····
Earnings per share, diluted-0.05-0.19-0.99r11.96-21.66·····
Earnings per share, basic and diluted····-21.50b-33.50b-36.00b-29.50b-18.50b-23.00b
Weighted average shares, basic11,569,00011,532,000r10,441,000rb9,028,0007,960,000r5,512,980b4,927,060b···
Weighted average shares, diluted11,569,00011,532,000r10,441r9,366,0007,960,000·····
Weighted average shares, basic and diluted····7,959,840b5,512,980rb4,927,060rb4,500,526b4,110,466b3,921,764b
As filed with the SEC, each figure from the newest report that carries it, and linked to it. Nothing here is computed.Share counts and per-share figures are on the newest report's basis, after the 1-for-50 reverse split of Dec 2022.A dot is a line not tagged for that period. r restated by the company in a later report; b a share figure put on the newest basis or filed in the wrong unit. Hover a figure for its filing and note.
What each line is, and the XBRL concept behind it
Revenue what customers paid for what it soldus-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
us-gaap:Revenues
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
us-gaap:SalesRevenueNet
Cost of revenue what it cost to make or buy what it soldus-gaap:CostOfGoodsAndServicesSold
us-gaap:CostOfGoodsSold
Gross profit revenue less the cost of what it soldus-gaap:GrossProfit
Research and development spent on inventing what it sells nextus-gaap:ResearchAndDevelopmentExpense
Selling, general and administrative the cost of selling and of running the companyus-gaap:SellingGeneralAndAdministrativeExpense
Sales and marketing the cost of finding and serving customersus-gaap:SellingAndMarketingExpense
General and administrative the cost of running the company itselfus-gaap:GeneralAndAdministrativeExpense
Total operating expenses the running costs togetherus-gaap:OperatingExpenses
Operating income profit from running the business, before interest and taxus-gaap:OperatingIncomeLoss
Interest expense what its borrowing costus-gaap:InterestExpenseDebt
us-gaap:InterestExpense
Interest and investment income what its cash and investments earnedus-gaap:InvestmentIncomeInterest
us-gaap:InterestIncomeOther
Other income (expense), net gains and costs outside the businessus-gaap:OtherNonoperatingIncomeExpense
Total non-operating income (expense) everything outside the business, togetherus-gaap:NonoperatingIncomeExpense
Income before income taxes profit before taxus-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
Income tax expense tax charged on the period's profitus-gaap:IncomeTaxExpenseBenefit
Income from continuing operations profit from the businesses it keepsus-gaap:IncomeLossFromContinuingOperations
Income from discontinued operations profit or loss from businesses it sold or closedus-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax
us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
Net income the profit or loss that belongs to the company's shareholdersus-gaap:NetIncomeLoss
Earnings per share, basic net income per share outstandingus-gaap:EarningsPerShareBasic
Earnings per share, diluted net income per share, counting every share that could be issuedus-gaap:EarningsPerShareDiluted
Earnings per share, basic and diluted net income per share, where both counts are the sameus-gaap:EarningsPerShareBasicAndDiluted
Weighted average shares, basic the average count of shares outstandingus-gaap:WeightedAverageNumberOfSharesOutstandingBasic
Weighted average shares, diluted the average count with every share that could be issuedus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Weighted average shares, basic and diluted the average count, where both counts are the sameus-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted
SI Assistanton TXMD · research, not advice